all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases serum albumin
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Serum albumin measured as part of the APACHE III score was increased in the vitamin A group as compared to the placebo group at Day 14 (See Table 2).”
Quoted verbatim from Vitamin A treatment for severe sepsis in humans; a prospective randomized double blind placebo-controlled clinical trial.. - Study
- RCT
- Duration
- 14 days
- Dose
- 100,000 IU daily for 7 days, intramuscular injection, versus placebo injection
- Population
- Adults with severe sepsis or septic shock in an ICU; day 14 value
Vitamin A treatment for severe sepsis in humans; a prospective randomized double blind placebo-controlled clinical trial.2019PMID:30661700Industry fundedPermalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against Serum albumin
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5JTPZ63ABX95GFX1Z1SKT0D